Co-Founder & CEO, Preclinical/Early Drug Discovery; SME on Protein X-ray Crystallography, Structural Biology, Biophysics, Chemistry and Structure-, Fragment and AI-Based Drug Discovery (SBDD, FBDD, AIDD).
We are excited to feature in the latest August 2025 issue of Life Sciences Insights, published by California Life Sciences (CLS). Our article “AI Drug Discovery & Development for DNA Damage Response (DDR) Oncology Therapeutics” (https://lnkd.in/gsC3XGC4) on page 14, highlights our efforts to combine our multimodal experimental data for AIDD. This edition, AI in Action: Real-World Innovation in Life Sciences, explores how artificial intelligence is transforming discovery, operations, and patient outcomes across the sector. We are honored to contribute to this important conversation and share our perspective alongside other industry leaders (read the full issue here https://lnkd.in/gc65PVQV). #drugdiscovery #therapeutics Accelero Biostructures XPose Therapeutics